BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 23314696)

  • 21. The Role of Grb2 in Cancer and Peptides as Grb2 Antagonists.
    Ijaz M; Wang F; Shahbaz M; Jiang W; Fathy AH; Nesa EU
    Protein Pept Lett; 2018 Feb; 24(12):1084-1095. PubMed ID: 29173143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and utilization of chiral alpha-methylated alpha-amino acids with a carboxyalkyl side chain in the design of novel Grb2-SH2 peptide inhibitors free of phosphotyrosine.
    Long YQ; Xue T; Song YL; Liu ZL; Huang SX; Yu Q
    J Med Chem; 2008 Oct; 51(20):6371-80. PubMed ID: 18821748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif.
    Lewitzky M; Kardinal C; Gehring NH; Schmidt EK; Konkol B; Eulitz M; Birchmeier W; Schaeper U; Feller SM
    Oncogene; 2001 Mar; 20(9):1052-62. PubMed ID: 11314042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2.
    Janes PW; Daly RJ; deFazio A; Sutherland RL
    Oncogene; 1994 Dec; 9(12):3601-8. PubMed ID: 7970720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solution structure of the Grb2 SH2 domain complexed with a high-affinity inhibitor.
    Ogura K; Shiga T; Yokochi M; Yuzawa S; Burke TR; Inagaki F
    J Biomol NMR; 2008 Nov; 42(3):197-207. PubMed ID: 18830565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solution structure of the SH2 domain of Grb2 complexed with the Shc-derived phosphotyrosine-containing peptide.
    Ogura K; Tsuchiya S; Terasawa H; Yuzawa S; Hatanaka H; Mandiyan V; Schlessinger J; Inagaki F
    J Mol Biol; 1999 Jun; 289(3):439-45. PubMed ID: 10356320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylation of growth factor receptor binding protein-2 by pp60c-src tyrosine kinase.
    Jones DA; Benjamin CW
    Arch Biochem Biophys; 1997 Jan; 337(2):143-8. PubMed ID: 9016807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of binding assays for the SH2 domain of Grb7 and Grb2 using fluorescence polarization.
    Luzy JP; Chen H; Gril B; Liu WQ; Vidal M; Perdereau D; Burnol AF; Garbay C
    J Biomol Screen; 2008 Feb; 13(2):112-9. PubMed ID: 18216394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sam68 associates with the SH3 domains of Grb2 recruiting GAP to the Grb2-SOS complex in insulin receptor signaling.
    Najib S; Sánchez-Margalet V
    J Cell Biochem; 2002; 86(1):99-106. PubMed ID: 12112020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basic study on SH2 domain of Grb2 as a molecular probe for detection of RTK activation.
    Saito Y; Furukawa T; Arano Y; Fujibayashi Y; Saga T
    Int J Oncol; 2010 Aug; 37(2):281-7. PubMed ID: 20596655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surface plasmon resonance thermodynamic and kinetic analysis as a strategic tool in drug design. Distinct ways for phosphopeptides to plug into Src- and Grb2 SH2 domains.
    de Mol NJ; Dekker FJ; Broutin I; Fischer MJ; Liskamp RM
    J Med Chem; 2005 Feb; 48(3):753-63. PubMed ID: 15689159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting SH2 domains in breast cancer.
    Morlacchi P; Robertson FM; Klostergaard J; McMurray JS
    Future Med Chem; 2014; 6(17):1909-26. PubMed ID: 25495984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A conformationally fixed analog of the peptide mimic Grb2-SH2 domain: synthesis and evaluation against the A431 cancer cell.
    Iwata T; Tanaka K; Tahara T; Nozaki S; Onoe H; Watanabe Y; Fukase K
    Mol Biosyst; 2013 May; 9(5):1019-25. PubMed ID: 23403766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells.
    Tari AM; Hung MC; Li K; Lopez-Berestein G
    Oncogene; 1999 Feb; 18(6):1325-32. PubMed ID: 10022814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of binding potency of peptidic inhibitors of Grb2-SH2 by using the protein-captured biosensor method.
    Lung FD; Li WC; Chang YH; Chen HM
    Protein Pept Lett; 2008; 15(8):808-10. PubMed ID: 18855753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of Grb2 SH2 Domain Proteins for Mirror-Image Screening Systems.
    Noguchi T; Ishiba H; Honda K; Kondoh Y; Osada H; Ohno H; Fujii N; Oishi S
    Bioconjug Chem; 2017 Feb; 28(2):609-619. PubMed ID: 28032751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transduced protein transduction domain linked HSP27 protected LECs against UVB radiation-induced damage.
    Liu L; Yu R; Shi Y; Dai Y; Zeng Z; Guo X; Ji Q; Wang G; Zhong J
    Exp Eye Res; 2014 Mar; 120():36-42. PubMed ID: 24444493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GRB2 dimerization mediated by SH2 domain-swapping is critical for T cell signaling and cytokine production.
    Sandouk A; Xu Z; Baruah S; Tremblay M; Hopkins JB; Chakravarthy S; Gakhar L; Schnicker NJ; Houtman JCD
    Sci Rep; 2023 Mar; 13(1):3505. PubMed ID: 36864087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic incorporation of a photo-crosslinkable amino acid reveals novel protein complexes with GRB2 in mammalian cells.
    Hino N; Oyama M; Sato A; Mukai T; Iraha F; Hayashi A; Kozuka-Hata H; Yamamoto T; Yokoyama S; Sakamoto K
    J Mol Biol; 2011 Feb; 406(2):343-53. PubMed ID: 21185312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The binding selectivity of the C-terminal SH3 domain of Grb2, but not its folding pathway, is dictated by its contiguous SH2 domain.
    Di Felice M; Pagano L; Pennacchietti V; Diop A; Pietrangeli P; Marcocci L; Di Matteo S; Malagrinò F; Toto A; Gianni S
    J Biol Chem; 2024 Apr; 300(4):107129. PubMed ID: 38432639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.